ProQR Therapeutics N.V. Ordinary Shares (PRQR) is a publicly traded Healthcare sector company. As of May 21, 2026, PRQR trades at $1.49 with a market cap of $159.10M and a P/E ratio of 0.00. PRQR moved +0.00% today. Year to date, PRQR is -29.90%; over the trailing twelve months it is -18.75%. Its 52-week range spans $1.07 to $4.62. Analyst consensus is strong buy with an average price target of $8.20. Rallies surfaces PRQR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
What are PRQR's key financials?
PRQR financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. PRQR recently traded at $1.49. Market cap is $159.10M. P/E ratio is 0.00. Revenue is $0.
PRQR financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. PRQR recently traded at $1.49. Market cap is $159.10M. P/E ratio is 0.00. Revenue is $0.
Is PRQR research on Rallies investment advice?
No. Rallies provides research, data, and educational context for PRQR. It does not provide personalized investment advice.
